EP2992013
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.4.2013EP published:
4.12.2019EP application number:
13721243.7
EPO information:
European Patent Register
Max expiry date:
28.4.2033
Title:
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
Timeline
Today
29.4.2013EP application
4.12.2019EP Publication
Owner
Name:
Teva Pharmaceuticals Australia Pty LtdAddress:
Level 2 37 Epping Road, Macquarie Park, NSW 2113, AU
Inventor
Name:
CLARKE, AdamAddress:
Macquarie Park, NSW 2113, AU
Name:
POLLARD, MatthewAddress:
Macquarie Park, NSW 2113, AU
Name:
DOYLE, Anthony, GerardAddress:
Macquarie Park, NSW 2113, AT
Name:
BEHRENS, ColletteAddress:
Macquarie Park, NSW 2113, AU
Name:
YAMAGISHI, TetsuoAddress:
Macquarie Park, NSW 2113, AU
Name:
WILSON, David, S. Jr.Address:
Redwood City, CA 94063, US
Name:
POGUE, Sarah, L.Address:
Freemont, CA 94555, US
Name:
TAURA, TetsuyaAddress:
Palo Alto, CA 94306, US
Classification
Categories:
C07K 16/28, C07K 14/00